Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
Learn more Dual GIP/GLP-1 receptor agonist with the highest average weight loss of any approved anti-obesity medication
The SURMOUNT-1 trial (tirzepatide, published in NEJM 2022) demonstrated that participants with obesity or overweight without diabetes who received tirzepatide experienced weight reductions of 16.0% (5mg), 21.4% (10mg), and 22.5% (15mg) over 72 weeks
Jos Francisco Kerr Saraiva is the national leader of the SOUL and SELECT trials
Book a BodySpec DEXA scan to track changes in lean mass, fat mass, and visceral fat
US$ 23.77
US$ 23.53
US$ 26.27
US$ 27.69
US$ 24.50
US$ 24.99
![Holon Lake (87/110) (Stamped) [EX: Holon Phantoms] Judge Gift Cards 2003](https://cdn.shopify.com/s/files/1/0567/4178/9882/products/f4cf4609-14cd-5453-9838-2c80503c5be6.jpg?v=1696292603)
